Sample Pretreatment for Human Fluids

Information

  • Research Project
  • 8715324
  • ApplicationId
    8715324
  • Core Project Number
    R43GM108239
  • Full Project Number
    1R43GM108239-01A1
  • Serial Number
    108239
  • FOA Number
    PA-11-215
  • Sub Project Id
  • Project Start Date
    9/8/2014 - 10 years ago
  • Project End Date
    6/30/2016 - 8 years ago
  • Program Officer Name
    FRIEDMAN, FRED K.
  • Budget Start Date
    9/8/2014 - 10 years ago
  • Budget End Date
    6/30/2015 - 9 years ago
  • Fiscal Year
    2014
  • Support Year
    01
  • Suffix
    A1
  • Award Notice Date
    9/8/2014 - 10 years ago
Organizations

Sample Pretreatment for Human Fluids

DESCRIPTION (provided by applicant): In this proposal we seek to develop a new method and instrument to reduce the complexity of protein mixtures derived from human fluids with an eye to discovery of very low-abundance protein biomarkers. The proposed method accomplishes two tasks: it reduces the dynamic range of the protein mixture by three or more orders of magnitude and it concentrates proteins by a factor of 100 or more so that low- abundance can be detected and concentration differences noted. The method does not use antibodies, combinatorial peptide libraries, carrier ampholytes or solid-liquid adsorption equilibria such as HPLC. The samples produced are compatible with 2D gel electrophoresis and 2D liquid chromatography tandem mass spectrometry approaches. By using different physical methods to separate the protein mixtures, the goal is to uncover new biomarkers that have eluded existing state-of-the-art methods. After development, the proposed method and instrument will be demonstrated using human plasma, where a sample from a lung cancer patient is compared with a reference that does not have cancer. Additional low-abundance proteins that are potential biomarkers will be uncovered when compared with traditional immunodepletion methods.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    265864
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:265864\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    SONATA BIOSCIENCES, INC.
  • Organization Department
  • Organization DUNS
    364221064
  • Organization City
    AUBURN
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    956045421
  • Organization District
    UNITED STATES